4.6 Article

Lack of p62 Impairs Glycogen Aggregation and Exacerbates Pathology in a Mouse Model of Myoclonic Epilepsy of Lafora

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

Suppression of glycogen synthesis as a treatment for Lafora disease: Establishing the window of opportunity

Olga Varea et al.

Summary: Lafora disease (LD) is a fatal adolescence-onset neurodegenerative condition characterized by the accumulation of aberrant glycogen aggregates known as Lafora bodies (LBs). Early suppression of glycogen synthase (MGS) can prevent LB formation and pathological manifestations of LD, but it is unclear whether late suppression of MGS can halt LB accumulation. Further research is needed to understand the potential therapeutic effects of targeting MGS in LD treatment.

NEUROBIOLOGY OF DISEASE (2021)

Article Clinical Neurology

Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease

Saija Ahonen et al.

Summary: Lafora disease is a fatal progressive myoclonus epilepsy caused by the accumulation of long branches in glycogen molecules leading to the formation of Lafora bodies. In mouse models, targeting the GYS1 mRNA with an antisense oligonucleotide (Gys1-ASO) prevented the formation of Lafora bodies and halted disease progression, showing promise as a potential therapy for this catastrophic epilepsy.
Article Clinical Neurology

Astrocytic glycogen accumulation drives the pathophysiology of neurodegeneration in Lafora disease

Jordi Duran et al.

Summary: Recent studies have shown that Lafora bodies are also present in astrocytes, not only in neurons. Blocking glycogen synthesis in astrocytes prevents the increase in neurodegeneration markers, autophagy impairment, and metabolic changes characteristic of the malin(KO) model.
Article Clinical Neurology

Targeting Gys1 with AAV-SaCas9 Decreases Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models

Emrah Gumusgoz et al.

Summary: Many adult and most childhood neurological diseases have a genetic basis, and CRISPR/Cas9 technology shows promise in treating them. By using CRISPR/Cas9 to disrupt gene sequences in adult polyglucosan body disease and Lafora disease mouse models, the researchers were able to reduce abnormal glycogen accumulation and improve neuroinflammatory markers, demonstrating the potential of this therapy for neurological diseases.

NEUROTHERAPEUTICS (2021)

Article Biochemistry & Molecular Biology

An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice

Silvia Nitschke et al.

Summary: The study demonstrates that knocking out Gys1 gene in LD mice can partially halt the progression of the disease but cannot fully reverse neurodegeneration and fatal epilepsy. While Gys1 knockout inhibits glycogen and Lafora body accumulation in skeletal muscle, it has some effect in preventing disease development in the brain. Additional research is needed to explore further mechanisms as glycogen and LBs still accumulate in certain tissues.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Multidisciplinary Sciences

The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration

Anne-Laure Mahul-Mellier et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Biochemistry & Molecular Biology

p62: Friend or Foe? Evidences forOncoJanusandNeuroJanusRoles

Sonia Emanuele et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Neurosciences

Lack of Astrocytic Glycogen Alters Synaptic Plasticity but Not Seizure Susceptibility

Jordi Duran et al.

MOLECULAR NEUROBIOLOGY (2020)

Article Cell Biology

Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion

M. Kathryn Brewer et al.

CELL METABOLISM (2019)

Article Neurosciences

Lack of Neuronal Glycogen Impairs Memory Formation and Learning-Dependent Synaptic Plasticity in Mice

Jordi Duran et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2019)

Review Biochemistry & Molecular Biology

p62/SQSTM1: 'Jack of all trades' in health and cancer

Pablo Sanchez-Martin et al.

FEBS JOURNAL (2019)

Article Biochemistry & Molecular Biology

P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity

Alexia F. Kalogeropulou et al.

BIOCHEMICAL JOURNAL (2018)

Article Biochemistry & Molecular Biology

Astrocytes: new players in progressive myoclonus epilepsy of Lafora type

Carla Rubio-Villena et al.

HUMAN MOLECULAR GENETICS (2018)

Review Biochemistry & Molecular Biology

Lafora disease offers a unique window into neuronal glycogen metabolism

Matthew S. Gentry et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

Article Multidisciplinary Sciences

Exploring the elusive composition of corpora amylacea of human brain

Elisabet Auge et al.

SCIENTIFIC REPORTS (2018)

Review Oncology

Glycogen metabolism and glycogen storage disorders

Shibani Kanungo et al.

ANNALS OF TRANSLATIONAL MEDICINE (2018)

Article Computer Science, Interdisciplinary Applications

lmerTest Package: Tests in Linear Mixed Effects Models

Alexandra Kuznetsova et al.

JOURNAL OF STATISTICAL SOFTWARE (2017)

Article Multidisciplinary Sciences

Neurotoxic reactive astrocytes are induced by activated microglia

Shane A. Liddelow et al.

NATURE (2017)

Review Cell Biology

Autophagy Receptors and Neurodegenerative Diseases

Zhiqiang Deng et al.

TRENDS IN CELL BIOLOGY (2017)

Article Multidisciplinary Sciences

QuPath: Open source software for digital pathology image analysis

Peter Bankhead et al.

SCIENTIFIC REPORTS (2017)

Review Biochemistry & Molecular Biology

Brain glycogen in health and disease

Jordi Duran et al.

MOLECULAR ASPECTS OF MEDICINE (2015)

Article Multidisciplinary Sciences

The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy

Michael Lazarou et al.

NATURE (2015)

Review Cell Biology

Cellular and metabolic functions for autophagy in cancer cells

Candia M. Kenific et al.

TRENDS IN CELL BIOLOGY (2015)

Article Biochemistry & Molecular Biology

Depletion of p62 reduces nuclear inclusions and paradoxically ameliorates disease phenotypes in Huntington's model mice

Masaru Kurosawa et al.

HUMAN MOLECULAR GENETICS (2015)

Article Cell Biology

Neuronal glycogen synthesis contributes to physiological aging

Christopher Sinadinos et al.

AGING CELL (2014)

Article Clinical Neurology

A New Muscle Glycogen Storage Disease Associated with Glycogenin-1 Deficiency

Edoardo Malfatti et al.

ANNALS OF NEUROLOGY (2014)

Article Biochemistry & Molecular Biology

Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease

Jordi Duran et al.

HUMAN MOLECULAR GENETICS (2014)

Article Endocrinology & Metabolism

Neurons have an active glycogen metabolism that contributes to tolerance to hypoxia

Isabel Saez et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)

Article Clinical Neurology

Polyglucosan Body Myopathy Caused by Defective Ubiquitin Ligase RBCK1

Johanna Nilsson et al.

ANNALS OF NEUROLOGY (2013)

Article Multidisciplinary Sciences

Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis

James C. Dodge et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Medicine, Research & Experimental

Deleterious effects of neuronal accumulation of glycogen in flies and mice

Jordi Duran et al.

EMBO MOLECULAR MEDICINE (2012)

Article Biochemistry & Molecular Biology

Dysfunctions in endosomal-lysosomal and autophagy pathways underlie neuropathology in a mouse model for Lafora disease

Rajat Puri et al.

HUMAN MOLECULAR GENETICS (2012)

Article Biochemistry & Molecular Biology

Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy

Olga Criado et al.

HUMAN MOLECULAR GENETICS (2012)

Article Medicine, Research & Experimental

Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease

Jordi Valles-Ortega et al.

EMBO MOLECULAR MEDICINE (2011)

Article Genetics & Heredity

PTG Depletion Removes Lafora Bodies and Rescues the Fatal Epilepsy of Lafora Disease

Julie Turnbull et al.

PLOS GENETICS (2011)

Article Clinical Neurology

Lafora Disease Epidemiology, Pathophysiology and Management

Thomas S. Monaghan et al.

CNS DRUGS (2010)

Editorial Material Cell Biology

p62, an autophagy hero or culprit?

Tor Erik Rusten et al.

NATURE CELL BIOLOGY (2010)

Review Biochemistry & Molecular Biology

Epilepsy, Regulation of Brain Energy Metabolism and Neurotransmission

Jean-Francois Cloix et al.

CURRENT MEDICINAL CHEMISTRY (2009)

Editorial Material Biochemistry & Molecular Biology

To aggregate or not to aggregate? A new role for p62

Jorge Moscat et al.

EMBO REPORTS (2009)

Review Mathematical & Computational Biology

Simultaneous inference in general parametric models

Torsten Hothorn et al.

BIOMETRICAL JOURNAL (2008)

Article Endocrinology & Metabolism

High glycogen levels in the hippocampus of patients with epilepsy

Mads K. Dalsgaard et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)

Review Cell Biology

Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide

Christian Haass et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)

Article Clinical Neurology

The presence of polyglucosan bodies in temporal lobe epilepsy: its role and significance

A Abubakr et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2005)

Article Biochemistry & Molecular Biology

Accumulation of high-molecular-weight amylose in Alzheimer's disease brains

LJ Huang et al.

GLYCOBIOLOGY (2004)